Skip to content Skip to navigation

Menactra Antitrust Litigation Settlement

Share
Active: 
Closed
Closed Settlement Statement: 
According to court documents, the claim submission deadline has passed. Please contact the claims administrator if you have any questions.
Settlement Structure: 
Case Summary: 

Sanofi has agreed to settle a class action alleging that it engaged in antitrust behavior, preventing competition and forcing customers to pay higher prices than necessary for its Menactra vaccine. Novartis was launching a competitor vaccine, and the complaint alleges that Sanofi required health care providers to buy the vaccine from it or risk paying much higher prices on Sanofi’s other pediatric vaccines. According to the complaint, this allowed Sanofi to maintain its monopoly of the market for that vaccine and artificially inflated prices.

Docket Number: 
2:11-cv-07178-JMV-MAH
Company: 
Sanofi Pasteur
Class Period: 
Monday, March 1, 2010 to Wednesday, December 31, 2014
Filing Deadline: 
Thursday, January 18, 2018
Objection Deadline: 
Monday, July 10, 2017
Exclusion Deadline: 
Monday, July 10, 2017
Final Approval Hearing: 
Tuesday, October 3, 2017
Menactra Packaging